Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




WellPoint Developing Drug Safety Monitoring System
Link ID 4881
Title WellPoint Developing Drug Safety Monitoring System
Url http://www.medscape.com/viewarticle/573019?src=rss
Description Health insurer WellPoint Inc said on Tuesday it is developing a system that will use its 35 million-member database to monitor and help to more quickly identify potential safety problems of approved medicines. Reuters Health Information
Category Articles > Business of Medicine
Keywords
Date Apr 16, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Business of Medicine
1. Scramble to Screen: Hospitalist Groups Revamp Admission Assessments Before Medicare Rules for Reimbu
  Medicare will begin denying reimbursement for certain conditions if they are acquired in the hospital. How are hospitalist groups refining their screening methods and what are the challenges?
The Hospitalist
Category:   Articles > Business of Medicine


2. Adverse Events in the Hospital Setting: How Safe Is Your Operating Room?
  Commentary on a study on in-hospital adverse events, published June 2008 in Quality and Safety in Health Care.
Medscape General Surgery
Category:   Articles > Business of Medicine


3. J&J Recalling Certain Lots of Drugs After Theft
  Johnson & Johnson said on Thursday it was voluntarily recalling specific lots of three of its medications to protect patients from receiving potentially mishandled or damaged products after a truck carrying the drugs was stolen. Reuters Health Information
Category:   Articles > Business of Medicine


4. Judge Denies Class in Fosamax Cases Against Merck
  A U.S. federal judge has denied motions to certify classes of users of osteoporosis drug Fosamax who wanted Merck & Co to set up a program to monitor them for an ailment involving jaw bone decay. Reuters Health Information
Category:   Articles > Business of Medicine


5. FDA Approves Combination Niacin and Simvastatin
  Simcor is approved for use in patients with complex lipid abnormalities where treatment with niacin or simvastatin alone is not sufficient. Heartwire
Category:   Articles > Business of Medicine




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS